What is prognosis of Diabetes?

['Obi kel párti li']

Kal ki é duénsa di diabétiku?

Pur isu, nu debe toma txeu kuidadu ku kel-li.

Diabétiti di tipu 1 é un duénsa di sistema imunológico ki ta poi korpu ka ta produzi insulina.

Ku tratamentu dretu, sima injeson di insulina, bon alimentason i izersísiu fíziku, pesoas ku diabeti di tipu 1 pode ten un vida kunpridu i saúdi.

Má, si nu ka toma kuidadu, el pode pô-nu ku prublémas di korason, duénsa di rinu, nervu i odju.

Diabéti di tipu 2 é pamodi algen ka ta toma insulina i txeu bês el sta ligadu ku manera di vive sima obesidadi i falta di atividadi fíziku.

Ku tratamentu dretu, sima medikamentu, dieta i izersísiu, pesoas ku diabeti di tipu 2 pode midjora ses kontrolu di asukar na sangi i redus risku di ten konplikason.

Alguns algen pode kura di duénsa di diabétiku di tipu 2 sô si es perde txeu pézu i es muda ses manera di vive.

Diabéti di grávida ta kontise duránti gravidadi i el ta kura di manera natural dipôs di partu.

Má, kes mudjer ki sufri diabeti duránti gravidês ten más xansi di panha más tardi diabeti di tipu 2.

Na geral, prognóstiku di diabeti é bon si é kontroladu dretu, mas é inportanti trabadja pertu ku un ekipa di kuidadus di saúdi pa monitora nível di asukar na sangi y faze mudansas nesesáriu na stilu di vida pa ivita konplikasons.

['Referénsia']

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Zhao XB, Ren GS: Diabetes mellitus and prognosis in women with breast cancer: A systematic review and meta-analysis. Medicine (Baltimore). 2016, 95 (49): e5602.

Ikeda Y, Shimada M, Hasegawa H, Gion T, Kajiyama K, Shirabe K, Yanaga K, Takenaka K, Sugimachi K: Prognosis of hepatocellular carcinoma with diabetes mellitus after hepatic resection. Hepatology. 1998, 27 (6): 1567-71.

Pallisgaard JL, Lindhardt TB, Olesen JB, Hansen ML, Carlson N, Gislason GH: Management and prognosis of atrial fibrillation in the diabetic patient. Expert Rev Cardiovasc Ther. 2015, 13 (6): 643-51.

Borch-Johnsen K: [Insulin-dependent diabetes mellitus--improved prognosis and insurance outlook]. Nord Med. 1992, 107 (8-9): 217-9.

Toyoda H, Kumada T, Nakano S, Takeda I, Sugiyama K, Kiriyama S, Tanikawa M, Sone Y, Hisanaga Y: Impact of diabetes mellitus on the prognosis of patients with hepatocellular carcinoma. Cancer. 2001, 91 (5): 957-63.

Gao RZ, Gu J, Du CZ, Li M: [Impact of diabetes mellitus on clinicopathological factors and prognosis of patients with colorectal cancer.]. Zhonghua Wai Ke Za Zhi. 2010, 48 (2): 88-92.

['Diskrison: médiku']

['Es site é sô pa studa i pa da informason.']

['Kes informason li ka debe uzadu pa faze diagnóstiku ô pa kura algun prubléma di saúdi.']

['Pur favor, toma nota ma redi neuronal ki ta jenera respóstas pa perguntas, é spesialmenti inakuradu óras ki ta papiadu di konteúdu numériku. Pur izénplu, nunbru di pesoas diagnostikadu ku un duénsa spesifiku.']

['Sénpri buska konsedju di bu médiku ó otu prestador di kuidadu di saúdi kualifikadu sobri un kondison médiku. Nunka ka bu nega konsedju di médiku profisional ô atrasa na buska-l pamodi algun kuza ki bu lé na es pájina. Si bu atxa ma bu pode ten un imerjénsia médiku, txoma 911 ô bai pa kuartu di imerjénsia más pértu imediatamenti.']

['Diskubri autor']

['Lei di Direitus Umanu Digital di 1998, 17 U.S.C. § 512 (o DMCA) ta dispunibiliza rikursus pa titular di direitus ki ta atxa ma material ki ta parsi na Internet ta viola ses direitus di akordu ku lei di direitus di autor di Stadus Unidus. ']

['Si bu kré, di bon fé, ki kualker kontiudu ô material disponibilizadu na nos site ô servisus ta viola bu direitus di autor, bo (ô bu ajenti) podi manda-nu un avizu ta pidi pa retiradu ô blokia es konteúdu ô material.']

['Nu ten ki manda un mensaji pa email (odja "Contact" pa kel email).']

['Es lei ta iziji ki bu notifikason di alegadu violason di copyright inklui kes siginti informason: (1) un deskripson di obra protejedu pa copyright ki e sujetu di alegadu violason; (2) un deskripson di kel konteúdu alegadu y informason sufisienti pa permiti-nu lokaliza kel konteúdu; (3) informason di kontatu pa bo, inkluindu bu enderesu, númeru di tilifon i enderesu di email; (4) un deklarason di bo ki ten un bon fé ma kel konteúdu di forma reklamadu ka e autorizadu pa donu di copyright, o pa se ajenti, o pa kualker lei; ']

['5. un deklarason di bu senhoriu, asinadu sob pena di perjúriu, ma informason na notifikason é izatu y ma bu ten autoridadi pa pratika kel direitu di autor ki foi violadu;']

['i (6) un asinatura fíziku ô iletróniku di kel algen ki é donu di direitus di autor ô di un algen ki sta autorizadu pa aji na se nómi.']

['Si bu ka da tudu informason, kel informason pode dimora txeu ténpu.']

['Kontaktu di Grupu']

['Pur favor, manda-nu email ku kalker pergunta/sugeston.']

What is prognosis of diabetes?

The prognosis of diabetes varies depending on the type of diabetes and how well it is managed.

Type 1 diabetes is an autoimmune disease where the body does not produce insulin, and it requires lifelong insulin therapy.

With proper management, including insulin injections, healthy diet, and regular exercise, individuals with type 1 diabetes can lead long and healthy lives.

However, if not managed properly, it can lead to complications such as heart disease, kidney disease, nerve damage, and eye problems.

Type 2 diabetes is caused by insulin resistance and is often associated with lifestyle factors such as obesity and lack of physical activity.

With proper management, including medication, diet, and exercise, individuals with type 2 diabetes can improve their blood sugar control and reduce the risk of complications.

In some cases, type 2 diabetes can even be reversed through significant weight loss and lifestyle changes.

Gestational diabetes occurs during pregnancy and usually resolves after delivery.

However, women with gestational diabetes have an increased risk of developing type 2 diabetes later in life.

Overall, the prognosis for diabetes is good if it is managed properly, but it is important to work closely with a healthcare team to monitor blood sugar levels and make necessary lifestyle changes to prevent complications.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.